July 2022 - Page 8 of 9 - NetworkNewsWire

FridayJul 08, 2022 9:00 am

Amid High Demand for American Commercial and Industrial Facilities Retrofitting, Correlate Infrastructure Partners Inc. (CIPI) Offers Solutions for Highly Affordable Clean Energy Implementation

Approximately 200,000 commercial and industrial properties need retrofit each year to comply with the timeline for the established 2050 carbon goals As sales transactions increase (sales transactions totaled $809 billion in 2021) in the commercial real estate industry, there is a higher demand for clean energy solutions Correlate Infrastructure Partners Inc. offers a complete suite of proprietary clean energy assessment solutions and a finance platform to reduce site-specific energy consumption and deploy clean energy solutions for commercial real estate properties The renewable energy market is expected to reach $1,977.6 billion by 2030, growing at a CAGR of 8.7% over the…

ThursdayJul 07, 2022 11:15 am

Gambling Market Setting New Records, a Perfect Storm Brewing for Golden Matrix Group Inc. (NASDAQ: GMGI)

The iGaming market is expected to reach $127 billion by 2027 Golden Matrix Group provides turnkey gaming platforms giving iGaming operators access to over 10,000 games, state of the art loyalty and customer retention systems GMGI recently acquired and 80% stake in RKings, helping boost revenue 221% in Q1 to $8.48 million as it ventures into the Mexican markets and ESports industry In 2021, the U.S. commercial gaming industry generated revenue of $53 billion, smashing the previous record set in 2019 at $43.65 billion. With new markets coming online, more records are almost certainly in the cards as evidenced by…

ThursdayJul 07, 2022 9:45 am

QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences Inc. is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical being evaluated for multiple indications CycloSam has been shown to cause significantly less buildup of long-lived radionuclidic impurities than prior FDA-approved drugs There is significant precedent that the radioisotope used in CycloSam, Samarium-153, is effective in treating bone cancer, as demonstrated in a published study conducted in over 500 patients using an older formulation of the drug There is also significant preliminary safety…

ThursdayJul 07, 2022 9:45 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) CEO, Chase Edgelow Featured on the Bell2Bell Podcast

EverGen Infrastructure CEO, Chase Edgelow, was recently featured on IBN’s Bell2Bell podcast Edgelow elucidated on the origins of the company as well as its commercial objectives going forward EverGen recently purchased a 50% stake in an Ontario-based RNG project, with a cumulative production capacity of 1.7 million GJ per year Chase Edgelow, Co-Founder and CEO of EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), a British-Columbia based Natural Gas operator, was recently featured on the latest episode of the InvestorBrandNetwork’s Bell2Bell Podcast, with Edgelow seizing on the opportunity to expand on EverGen’s business model and operating markets (https://nnw.fm/XWz4x). Edgelow separately elaborated on…

ThursdayJul 07, 2022 9:00 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Daniel Brody, Director, Continues To Buy More Shares

Daniel Brody, Eat Well’s Co-Founder and Director, has, since June 29, 2022, been buying shares in the company, totaling 8,430,625 as of June 29, 2022 His purchases highlight his confidence in the company’s current trajectory and its commitment to creating shareholder value Eat Well maintains that its revenue guidance for its investee companies still stands at $90 million to $110 million for the 2022 fiscal year The past year was monumental for Eat Well Investment Group (CSE: EWG) (OTC: EWGFF). Most notably, it marked the company’s market expansion following partnerships with vital retail companies in the United States and Canada,…

WednesdayJul 06, 2022 12:45 pm

DGE’s 2nd Chief Patient Officer Summit Is Designed To Ensure Best Practices For A Seamless and Beneficial Patient Experience

DGE’s 2nd Chief Patient Officer Summit being held on July 19-20, 2022 in Boston, MA is attended by industry leaders who offer valuable advice on the best practices for building trusted long-term relationships with patients, caregivers, and advocates. They offer their insights on cultivating a corporate culture dedicated to providing the best possible patient experience. Previous coverage of this topic has been applauded, where dignitaries dedicated to patient advocacy, engagement, education, and communication, all discussed how a patient’s opinion is critical and integrated into discovery research, clinical studies, and post-approval. The event is hosted by Dynamic Global Events (“DGE”), a…

WednesdayJul 06, 2022 12:00 pm

Correlate Infrastructure Partners Inc. (CIPI) Helps Companies Attain Sustainability Objectives

Correlate Infrastructure Partners is known for executing portfolio-scale renewable energy and efficiency upgrades across the U.S. With a recent study observing that more CEOs are now prioritizing sustainability, the market is clearly growing for Correlate’s services Correlate helps companies deal with some of the key challenges identified in the study, including concerns about the return on investment and economic benefits, lack of insights from data, inadequate skills, and general technological barriers Correlate funds, designs, engineers, and builds sustainability-focused projects in addition to providing the technical expertise through its team of energy experts, and in a way that makes sustainability compellingly…

WednesdayJul 06, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Optimistic About Drug/Tech IP as Industry Studies Big Pharma M&A Outlook

Biopharma industry analysts have been expecting 2022 to be a heady year for big-pharma acquisitions or partnerships with promising medical upstarts following a time period that has left the biggest companies flush with cash Among promising device and drug developers, Odyssey Health Inc. has been working on novel solutions to brain concussion injuries, a rare neurodegenerative disease, obstructive choking incidents and early-stage coronary artery disease (“CAD”) detection Odyssey Health Inc. is taking its brain concussion solution to a Phase 1 clinical human trial currently with possible progression to Phase 2 before the end of the year The company likewise anticipates…

WednesdayJul 06, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Production Capabilities to Support Growing List of Business-to-Business Clientele

Lexaria is a global innovator in drug delivery platforms; its patented DehydraTECH(TM) technology improves the bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“API”) Testing confirms that DehydraTECH-processed cannabidiol beverages maintained 93.4% and 78% potency of CBD a full year and two years after production, respectively Lexaria recently signed two agreements with BevNology LLC, an Atlanta-based company with advanced capabilities that support best-in-class beverage formulations The partnership, which also leverages Lexaria’s superior DehydraTECH-CBD nanoemulsification formulation and processing techniques, could make industry-leading beverage products a reality for many brands In this year’s letter to shareholders, Lexaria Bioscience (NASDAQ:…

WednesdayJul 06, 2022 9:45 am

Mobile Tech Services Provider FingerMotion Inc. (NASDAQ: FNGR) Strengthening Revenues With China’s Expanding User Base

U.S.-based mobile communications technology services provider FingerMotion is a China-focused innovator building revenues in the cell phone and reinsurance markets China recently reinforced its interest in seeing mobile payments and financial technology platforms playing a larger part in its developing economic strategy for strengthening its internal domestic consumerism FingerMotion recently reported annual financial data that showed revenue had grown by 37 percent during last year with 297 percent growth in its big data revenue and 170 percent growth in telecommunications products and services China has an estimated 1.4 billion mobile users, and market analysts predict mobile engagement there will grow…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: July 2022